Revolution Medicines, Inc. (RVMDW)

NASDAQ: RVMDW · Real-Time Price · USD · Warrants
0.1200
-0.0686 (-36.37%)
May 15, 2025, 4:00 PM - Market closed
-36.37%
Market Cap 7.35B
Revenue (ttm) n/a
Net Income (ttm) -697.51M
Shares Out 186.27M
EPS (ttm) -4.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 742
Open 0.1300
Previous Close 0.1886
Day's Range 0.1200 - 0.2000
52-Week Range 0.1050 - 0.1490
Beta 1.12
Analysts n/a
Price Target n/a
Earnings Date Feb 26, 2025

About RVMDW

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company’s research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236)... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 534
Stock Exchange NASDAQ
Ticker Symbol RVMDW
Full Company Profile

Financial Performance

News

There is no news available yet.